Multiplex-PCR Assay

Biotype Diagnostic

The positioning of diagnostic test systems in the medical market is complex, time consuming, and expensive. Health professionals accept innovation in routine diagnostic applications only on the basis of evidence based medicine (EBM).

This project is designed to validate an existing multiplex-pcr assay by independent investigators, thereby facilitating its admission to medical guidelines.

Answering the EBM requirement we expect a significantly better acceptance of the application by health professionals, a deeper market penetration and higher revenues from our product.

Get in contact